Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes

Clinical trial NCT04997811 · UNKNOWN

Trial details

NCT number: NCT04997811
Sponsor: Prof. Janet Dunn
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes (MDS)

Start date: 2021-12-21
Primary completion: 2025-01-31
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.